Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 Oct;46(10):722–726. doi: 10.1136/thx.46.10.722

Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS.

D S Robinson 1, D A Cunningham 1, S Dave 1, J Fleming 1, D M Mitchell 1
PMCID: PMC463391  PMID: 1750019

Abstract

Various non-invasive investigations were carried out in patients infected with HIV who had respiratory symptoms with and without pneumocystis pneumonia (with pneumonia, n = 13 (five smokers); without pneumonia, n = 22 (13 smokers]. These included chest radiography; lung function tests (forced expiratory volume in one second, forced vital capacity; transfer factor and coefficient for carbon monoxide); arterial blood gas tensions; arterial oxygen saturation at rest and on exercise; and lung clearance of diethylenetriaminepenta-acetic acid labelled with technetium-99m (99mTc DTPA). The effect of scan time (seven v 45 minutes from peak counts) and subtraction of background counts were examined. There were no significant differences between the two groups in lung function tests or arterial blood gas tensions at rest. The median clearance half time of inhaled 99mTc DTPA for the first seven minutes from peak counts was 7.2 minutes for patients with pneumocystis pneumonia and 22 minutes for those without. The median arterial oxygen desaturation on exercise was 5% in patients with pneumocystis pneumonia and 2% in those without. 99mTc DTPA lung clearance was better than the other non-invasive tests in discriminating pneumocystis pneumonia from other pulmonary disorders in patients positive for HIV. A short scan time of seven minutes was as sensitive and specific as the longer scan time of 45 minutes, and this allows the clearance of 99mTc DTPA to become a rapid screening test.

Full text

PDF
722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coleman D. L., Dodek P. M., Golden J. A., Luce J. M., Golden E., Gold W. M., Murray J. F. Correlation between serial pulmonary function tests and fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984 Mar;129(3):491–493. doi: 10.1164/arrd.1984.129.3.491. [DOI] [PubMed] [Google Scholar]
  2. Engelberg L. A., Lerner C. W., Tapper M. L. Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984 Oct;130(4):689–694. doi: 10.1164/arrd.1984.130.4.689. [DOI] [PubMed] [Google Scholar]
  3. Fischl M. A., Dickinson G. M., La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988 Feb 26;259(8):1185–1189. doi: 10.1001/jama.259.8.1185. [DOI] [PubMed] [Google Scholar]
  4. Greenspan J. S., Mastrucci M. T., Leggott P. J., Freese U. K., De Souza Y. G., Scott G. B., Greenspan D. Hairy leukoplakia in a child. AIDS. 1988 Apr;2(2):143–143. [PubMed] [Google Scholar]
  5. Jones J. G., Minty B. D., Lawler P., Hulands G., Crawley J. C., Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980 Jan 12;1(8159):66–68. doi: 10.1016/s0140-6736(80)90493-6. [DOI] [PubMed] [Google Scholar]
  6. Jones J. G., Minty B. D., Royston D. The physiology of leaky lungs. Br J Anaesth. 1982 Jul;54(7):705–721. doi: 10.1093/bja/54.7.705-a. [DOI] [PubMed] [Google Scholar]
  7. Langford J. A., Lewis C. A., Gellert A. R., Tolfree S. E., Rudd R. M. Pulmonary epithelial permeability: vascular background effects on whole lung and regional half-time values. Nucl Med Commun. 1986 Mar;7(3):183–190. [PubMed] [Google Scholar]
  8. Miller R. F., Millar A. B., Weller I. V., Semple S. J. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax. 1989 Jul;44(7):559–564. doi: 10.1136/thx.44.7.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mitchell D. M. Diagnostic problems in AIDS and the lung. Respir Med. 1989 Jan;83(1):9–14. doi: 10.1016/s0954-6111(89)80053-8. [DOI] [PubMed] [Google Scholar]
  10. Mitchell D. M., Solomon M. A., Tolfree S. E., Short M., Spiro S. G. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax. 1987 Jun;42(6):457–461. doi: 10.1136/thx.42.6.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Montgomery A. B., Debs R. J., Luce J. M., Corkery K. J., Turner J., Brunette E. N., Lin E. T., Hopewell P. C. Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Aug 29;2(8557):480–483. doi: 10.1016/s0140-6736(87)91794-6. [DOI] [PubMed] [Google Scholar]
  12. O'Doherty M. J., Page C. J., Bradbeer C. S., Shahmanesh M., Edwards A., Barlow D., Nunan T. O., Bateman N. T. The place of lung 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV positive patients. Respir Med. 1989 Sep;83(5):395–401. doi: 10.1016/s0954-6111(89)80071-x. [DOI] [PubMed] [Google Scholar]
  13. O'Doherty M. J., Page C. J., Croft D. N., Bateman N. T. Lung 99Tcm-DTPA transfer: a method for background correction. Nucl Med Commun. 1985 Apr;6(4):209–215. doi: 10.1097/00006231-198504000-00004. [DOI] [PubMed] [Google Scholar]
  14. Rosen M. J., Tow T. W., Teirstein A. S., Chuang M. T., Marchevsky A., Bottone E. J. Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax. 1985 Aug;40(8):571–575. doi: 10.1136/thx.40.8.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shaw R. J., Roussak C., Forster S. M., Harris J. R., Pinching A. J., Mitchell D. M. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax. 1988 Jun;43(6):436–440. doi: 10.1136/thx.43.6.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smith D. E., McLuckie A., Wyatt J., Gazzard B. Severe exercise hypoxaemia with normal or near normal X-rays: a feature of Pneumocystis carinii infection. Lancet. 1988 Nov 5;2(8619):1049–1051. doi: 10.1016/s0140-6736(88)90066-9. [DOI] [PubMed] [Google Scholar]
  17. Stover D. E., White D. A., Romano P. A., Gellene R. A., Robeson W. A. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. doi: 10.1016/0002-9343(85)90334-1. [DOI] [PubMed] [Google Scholar]
  18. Suster B., Akerman M., Orenstein M., Wax M. R. Pulmonary manifestations of AIDS: review of 106 episodes. Radiology. 1986 Oct;161(1):87–93. doi: 10.1148/radiology.161.1.3489955. [DOI] [PubMed] [Google Scholar]
  19. Yoneda K., Walzer P. D. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect Immun. 1980 Aug;29(2):692–703. doi: 10.1128/iai.29.2.692-703.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES